Recently, the ratio of native to cysteinylated TTR in cerebrospinal fluid has been suggested as a useful diagnostic tool for Alzheimer’s disease (Biroccio et al. 2006). The gene discussed is TTR; the disease is early-onset autosomal dominant Alzheimer disease.